Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 Countries.
Adult
Age Factors
Blood Pressure
Body Mass Index
Cross-Sectional Studies
Developing Countries
/ economics
Diagnostic Screening Programs
Female
Health Surveys
Humans
Hypertension
/ diagnosis
Income
Male
Middle Aged
Obesity
/ diagnosis
Predictive Value of Tests
Prevalence
Prognosis
Risk Assessment
Risk Factors
Sex Factors
Smoking
/ adverse effects
cardiovascular disease
epidemiology
low‐ and middle‐income countries
noncommunicable diseases
prevention
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
06 07 2021
06 07 2021
Historique:
pubmed:
3
7
2021
medline:
30
10
2021
entrez:
2
7
2021
Statut:
ppublish
Résumé
Background As screening programs in low- and middle-income countries (LMICs) often do not have the resources to screen the entire population, there is frequently a need to target such efforts to easily identifiable priority groups. This study aimed to determine (1) how hypertension prevalence in LMICs varies by age, sex, body mass index, and smoking status, and (2) the ability of different combinations of these variables to accurately predict hypertension. Methods and Results We analyzed individual-level, nationally representative data from 1 170 629 participants in 56 LMICs, of whom 220 636 (18.8%) had hypertension. Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or reporting to be taking blood pressure-lowering medication. The shape of the positive association of hypertension with age and body mass index varied across world regions. We used logistic regression and random forest models to compute the area under the receiver operating characteristic curve in each country for different combinations of age, body mass index, sex, and smoking status. The area under the receiver operating characteristic curve for the model with all 4 predictors ranged from 0.64 to 0.85 between countries, with a country-level mean of 0.76 across LMICs globally. The mean absolute increase in the area under the receiver operating characteristic curve from the model including only age to the model including all 4 predictors was 0.05. Conclusions Adding body mass index, sex, and smoking status to age led to only a minor increase in the ability to distinguish between adults with and without hypertension compared with using age alone. Hypertension screening programs in LMICs could use age as the primary variable to target their efforts.
Identifiants
pubmed: 34212779
doi: 10.1161/JAHA.121.021063
pmc: PMC8403275
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e021063Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR003143
Pays : United States
Références
Blood Press Monit. 1996 Feb;1(1):55-61
pubmed: 10226203
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Nutrients. 2020 Dec 23;13(1):
pubmed: 33374524
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
JAMA Intern Med. 2018 Mar 1;178(3):363-372
pubmed: 29379964
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Vasc Health Risk Manag. 2011;7:709-17
pubmed: 22174581
Med Biol Eng Comput. 2011 Jul;49(7):719-22
pubmed: 21597999
Vasc Health Risk Manag. 2007;3(4):389-400
pubmed: 17969368
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Circulation. 2012 May 8;125(18):2204-2211
pubmed: 22492580
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
PLoS One. 2019 Aug 19;14(8):e0215045
pubmed: 31425568
Blood Press Monit. 2003 Jun;8(3):127-33
pubmed: 12900590
Diabetes Care. 2012 Dec;35(12):2650-64
pubmed: 23100048
J Hum Hypertens. 2000 Jul;14(7):423-7
pubmed: 10918546
Hypertension. 2019 Apr;73(4):770-776
pubmed: 30739534
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
Ann Intern Med. 2015 Feb 3;162(3):184-91
pubmed: 25531552
BMC Cardiovasc Disord. 2016 Jan 13;16:9
pubmed: 26758197
Lancet. 2016 Aug 20;388(10046):761-75
pubmed: 27431356
Arq Bras Cardiol. 2009 Jan;92(1):10-5
pubmed: 19219259
Blood Press Monit. 2009 Jun;14(3):132-5
pubmed: 19433979
PLoS One. 2015 Jun 10;10(6):e0130218
pubmed: 26061419
BMC Bioinformatics. 2017 Mar 14;18(1):169
pubmed: 28292263
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Lancet Glob Health. 2019 Oct;7(10):e1332-e1345
pubmed: 31488387
Blood Press Monit. 2000 Aug;5(4):227-31
pubmed: 11035865
Int Health. 2015 Jul;7(4):262-5
pubmed: 25525132
N Engl J Med. 2014 Aug 28;371(9):818-27
pubmed: 25162888
Blood Press Monit. 2006 Jun;11(3):165-71
pubmed: 16702826
Hypertension. 2013 Jul;62(1):18-26
pubmed: 23670299
J Am Heart Assoc. 2021 Jul 6;10(13):e021063
pubmed: 34212779